Patrick Chomez
8Patents
3h-index
14Co-inventors
54Inventor score
Filing activity: Dec 12, 1991 → Jun 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5342774A | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 | Human Necessities | 140 | Expired |
| US5612201A | Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor | Chemistry; Metallurgy | 91 | Expired |
| US5925729A | Tumor rejection antigen precursors, tumor rejection antigens and uses thereof | Emerging Cross-Sectional Technologies | 20 | Expired |
| US10040832B2 | UspA2 protein constructs and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10947280B2 | UspA2 protein constructs and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US7923534B1 | Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 | Emerging Cross-Sectional Technologies | 0 | Expired |
| US10745449B2 | UspA2 protein constructs and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| USRE40089E1 | Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor | General | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.